Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05 2021 - 8:00AM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will present a corporate
overview at the 39th Annual J.P. Morgan Healthcare Conference on
Wednesday, January 13th at 5:20pm EST.
The virtual session will be webcast live and may be accessed via
a link on the Sangamo Therapeutics website in the Investors and
Media section under Events and Presentations. The presentation will
also be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and genome regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005148/en/
Investor Relations & Media
Inquiries Aron Feingold 628.252.7494
afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024